I agree that this site is using cookies. You can find further informations here.
X
de Castro Carpeño, J.
165  results:
Search for persons X
?
1

138P Faecalibacterium prausnitzii enhances tumor response t..:

Rodriguez-Festa, A. ; Serna-Blasco, R. ; Nadal, E....
ESMO Open.  9 (2024)  - p. 102725 , 2024
Link: https://doi.org/10.1016/..
 
?
2

EP11.03-05 Molecular Characterization and Prognosis of Pati..:

Gutiérrez Sainz, L. ; Villamayor, J. ; Higuera, O....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S620-S621 , 2023
Link: https://doi.org/10.1016/..
 
?
3

187P Tissue B-cell receptor repertoire as biomarker of comp..:

Sierra-Rodero, B. ; Martínez-Toledo, C. ; Molina-Alejandre, M....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S141-S142 , 2023
Link: https://doi.org/10.1016/..
 
?
4

EP16.01-007 Molecular Characterization by Next-Generation S..:

Castellanos, P. Cruz ; Alonso, R. Rosas ; Ozaez, I....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S558 , 2022
Link: https://doi.org/10.1016/..
 
?
5

EP08.02-088 Mutational Status of KRAS, STK11 and CDKN2A Gen..:

Cruz Castellanos, P. ; Rosas Alonso, R. ; Ozaez, I....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S443-S444 , 2022
Link: https://doi.org/10.1016/..
 
?
6

EP08.01-048 Spanish Immunotherapy Registry of Cardiovascula..:

Gutiérrez Sainz, L. ; Cruz Castellanos, P. ; Higuera Gómez, O....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S361-S362 , 2022
Link: https://doi.org/10.1016/..
 
?
7

2MO First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) in ..:

Gettinger, S. ; Schenker, M. ; De Langen, J....
Immuno-Oncology and Technology.  16 (2022)  - p. 100107 , 2022
Link: https://doi.org/10.1016/..
 
?
8

OA02.03 Tumor Bulk-RNA Seq Identifies Patients at High Risk..:

Casarrubios, M. ; Cruz-Bermúdez, A. ; Sierra-Rodero, B....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S6-S7 , 2022
Link: https://doi.org/10.1016/..
 
?
9

EP16.02-014 A Comparative Analysis of Gene Alteration Detec..:

Ozaez, I. ; Hernández, I. ; Cruz-Castellanos, P....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S577 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Prevention of chemotherapy-induced nausea and vomiting in t..:

Escobar Álvarez, Y. ; De Castro Carpeño, J. ; Bell, D...
Clinical and Translational Oncology.  23 (2021)  10 - p. 2155-2162 , 2021
Link: https://doi.org/10.1007/..
 
?
11

Five-year outcomes from the randomized, phase 3 trials Chec..:

Lind, M. ; Gettinger, S. ; Borghaei, H....
Lung Cancer.  139 (2020)  - p. S49-S50 , 2020
Link: https://doi.org/10.1016/..
 
?
12

PACIFIC: Overall Survival with Durvalumab versus Placebo af..:

Raben, D. ; Faivre-Finn, C. ; Spigel, D....
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  5 - p. 1607-1608 , 2018
Link: https://doi.org/10.1016/..
 
?
13

NSCLC Patients With Brain Metastases Treated With Platinum-..:

Smit, E. ; Moro-Sibilot, D. ; de Castro Carpeño, J....
International Journal of Radiation Oncology*Biology*Physics.  90 (2014)  5 - p. S47 , 2014
Link: https://doi.org/10.1016/..
 
?
14

PCN126 OVERVIEW OF PRIMARY ENDPOINTS, PROGRESSION-FREE SURV..:

Heron, L. ; De Castro Carpeño, J. ; Chouaid, C....
Value in Health.  14 (2011)  3 - p. A177-A178 , 2011
Link: https://doi.org/10.1016/..
 
?
15

PCN7 COMPARATIVE EFFECTIVENESS ASSESSMENT OF ERLOTINIB VERS..:

Schwander, B. ; de Castro Carpeño, J. ; Heigener, D.F....
Value in Health.  14 (2011)  3 - p. A155 , 2011
Link: https://doi.org/10.1016/..
 
1-15